跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SCMC SYRUP 100 100 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
SCMC SYRUP 100 100 MG/5 ML
Approved
THERAPEUTIC
SCMC SYRUP 100 100 MG/5 ML
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 22, 1989
Approval ID
da6fdb2c92d31b34
Company
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
da6fdb2c92d31b34
Drug Name
SCMC SYRUP 100 100 MG/5 ML
Product Name
SCMC SYRUP 100 100 MG/5 ML
Approval Number
SIN02852P
Approval Date
1989-05-22
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CB03
Atc Item Name
carbocisteine
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path
/organization/beacons-pharmaceuticals-pte-ltd
Active Ingredients
CARBOCISTEINE
100 mg/5 ml
CARBOCISTEINE
100 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 22, 1989
Approval ID
da6fdb2c92d31b34
Type
Therapeutic
Back to HSA Approvals